RxDoctor Payments Data

Matthew Wilhelm, DO

Interventional Pain Medicine · Tampa, FLNPI 1255960225

Payments from drug & device makers

What this record shows

This record is dominated by grants: $7,500 of the $9,960 with a category attached, or 75.3%. Medtronic accounts for 79.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $8,510 and has fallen 87.3% since, to $1,085 in 2025.

$9,960in general payments, 2019–2025

Across 25 payments — averaging $398.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Boston Scientific$562
  • Merz Pharmaceuticals, LLC$493
  • Abbott$477
  • Amgen$246
  • SPR Therapeutics, Inc$153
  • plus $138 from 3 others

What the payments were for

  • Grants$7,50075%
  • Travel & lodging$1311%
  • Food & beverage$2,24923%
  • Education$801%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic4$7,891
Boston Scientific5$562
Merz Pharmaceuticals, LLC5$493
Abbott5$477
Amgen2$246
SPR Therapeutics, Inc1$153
Curonix LLC1$64
Ipsen Biopharmaceuticals, Inc1$60
Microtransponder, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,960 in reported general payments places this provider in the 70th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$12,016
Medicare patients
56
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →